4
Changes in Ownership
Lipocine Inc. Filed Acc 0001638599-20-000977
Chief Executive Officer sold 15,000 shares at $1.35 ($20,250)
- Chief Executive Officer acquired 45,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Mahesh V. Chief Executive Officer | 2020-12-16 | Option exercise | +45,000 | 1,243,090 | D | ||
| Patel Mahesh V. Chief Executive Officer | 2020-12-16 | Sale | −15,000 | $1.35 | $20,250 | 1,228,090 | D |
| Derivatives | |||||||
| Patel Mahesh V. Chief Executive Officer | 2020-12-15 | Grant or award · Stock Option (Right to Buy) | +375,000 | $1.37 | $513,750 | 375,000 | D |
| Patel Mahesh V. Chief Executive Officer | 2020-12-16 | Option exercise · Restricted Stock Unit | +45,000 | 45,000 | D | ||
| Open-market sales · 15,000 sh · avg $1.35 · $20,250 | |||||||
Loading xslF345X03/doc4_6960.xml…